MDM2 and liver cancer: Several epidemiological studies have evaluated the association of TP53 codon 72 and MDM2 SNP309 polymorphisms and risk of or survival from several types of cancer [22-24], but few evaluated the association of both these polymorphisms in viral-related liver cancer and none in hepatocellular carcinoma from Italian patients.